The primary objective of this multicenter randomized controlled study is to compare the safety and efficacy of minimally invasive hematoma evacuation with the Artemis NeuroEvacuation Device to best medical management for the treatment of intracerebral hemorrhage (ICH).
Principal Investigator(s)
Award Info
Penumbra, Inc.